{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:45:51Z","timestamp":1792633551841,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009530","name":"Assam University, Silchar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.cimid.2020.101574","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T02:06:32Z","timestamp":1605492392000},"page":"101574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"special_numbering":"C","title":["Drug resistant Tuberculosis: A review"],"prefix":"10.1016","volume":"74","author":[{"given":"Jessy Lallungawi","family":"Khawbung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durbba","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriyo","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cimid.2020.101574_bib0005","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/gbe\/evw068","article-title":"Expression-linked patterns of codon usage, amino acid frequency, and protein length in the basally branching Arthropod Parasteatoda tepidariorum","volume":"8","author":"Whittle","year":"2016","journal-title":"Genome Biol. Evol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0012-3692(15)50981-1","article-title":"Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control","volume":"130","author":"Sharma","year":"2006","journal-title":"Chest"},{"issue":"10181","key":"10.1016\/j.cimid.2020.101574_bib0015","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cimid.2020.101574_bib0020","series-title":"World Health Organization Multidrug and Extensively Drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance Andresponse","author":"W.H. Organization","year":"2010"},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.cimid.2020.101574_bib0030","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015","volume":"19","author":"Zhang","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.coph.2011.07.001","article-title":"A new evolutionary and pharmacokinetic\u2013pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs","volume":"11","author":"Pasipanodya","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.cimid.2020.101574_bib0040","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","article-title":"Antibiotic resistance mechanisms in M. tuberculosis: an update","volume":"90","author":"Nguyen","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.80","article-title":"Persisters, persistent infections and the Yin\u2013Yang model","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/380795","article-title":"Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis","volume":"38","author":"Gurumurthy","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cimid.2020.101574_bib0055","series-title":"The Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis, Multidrug-resistant Tuberculosis","first-page":"77","author":"Takiff","year":"2000"},{"key":"10.1016\/j.cimid.2020.101574_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","article-title":"Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment","volume":"42","author":"Koch","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5157","key":"10.1016\/j.cimid.2020.101574_bib0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.8153626","article-title":"Resistance to antibiotics mediated by target alterations","volume":"264","author":"Spratt","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cimid.2020.101574_bib0070","doi-asserted-by":"crossref","DOI":"10.21037\/jphe.2016.12.08","article-title":"Tuberculosis\u2014an overview","volume":"1","author":"Agyeman","year":"2017","journal-title":"J. Public Health Emerg."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.191.2.287","article-title":"Inhibition of Ca2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome\u2013lysosome fusion and increased survival within human macrophages","volume":"191","author":"Malik","year":"2000","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.F293","article-title":"The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years","volume":"32","author":"Schluger","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cimid.2020.101574_bib0090","first-page":"459","article-title":"Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses\u2014dual mechanisms that control bacillary multiplication, Tuberculosis","author":"Dannenberg","year":"1994","journal-title":"Am. Soc. Microbiol."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0095","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","volume":"49","author":"Falzon","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.47.3.833-836.2003","article-title":"Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary","volume":"47","author":"Grosset","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.cimid.2020.101574_bib0105","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1378\/chest.14-1286","article-title":"Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide eff ectiveness","volume":"147","author":"Miotto","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1099\/mic.0.27629-0","article-title":"Genetic analysis of the \u03b2-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to \u03b2-lactam antibiotics","volume":"151","author":"Flores","year":"2005","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tube.2008.02.004","article-title":"Identification of outer membrane proteins of Mycobacterium tuberculosis","volume":"88","author":"Song","year":"2008","journal-title":"Tuberculosis"},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005561","article-title":"Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review","volume":"4","author":"Suchindran","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0130","first-page":"187","article-title":"Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance","volume":"2","author":"Lipsitch","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0135","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/AAC.01486-07","article-title":"Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin","volume":"52","author":"Safi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"33","key":"10.1016\/j.cimid.2020.101574_bib0140","doi-asserted-by":"crossref","first-page":"11863","DOI":"10.1073\/pnas.0804739105","article-title":"Accumulation of mutants in \u201caging\u201d bacterial colonies is due to growth under selection, not stress-induced mutagenesis","volume":"105","author":"Wrande","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid0402.980207","article-title":"Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives","volume":"4","author":"Rattan","year":"1998","journal-title":"Emerging Infect. Dis."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.actatropica.2011.04.008","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing","volume":"119","author":"Laurenzo","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.cimid.2020.101574_bib0155","series-title":"Heinemann Medical Books","article-title":"The use of antibiotics: a comprehensive review with clinical emphasis","author":"Kucers","year":"1979"},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0923-2508(93)90023-U","article-title":"Multidrug-resistant tuberculosis and its control","volume":"144","author":"Kochi","year":"1993","journal-title":"Res. Microbiol."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0170","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00352535","article-title":"Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the \u03b2 subunit gene of the rifampicin resistant rpoB255 mutant","volume":"184","author":"Ovchinnikov","year":"1981","journal-title":"Molecular and General Genetics MGG"},{"key":"10.1016\/j.cimid.2020.101574_bib0175","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0076-6879(96)73027-6","article-title":"Mutational analysis of structure-function relationship of RNA polymerase in Escherichia coli","author":"Jin","year":"1996","journal-title":"Methods Enzymol."},{"issue":"12","key":"10.1016\/j.cimid.2020.101574_bib0180","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/resp.13393","article-title":"Drug resistance mechanisms and drug susceptibility testing for tuberculosis","volume":"23","author":"Miotto","year":"2018","journal-title":"Respirology"},{"issue":"24","key":"10.1016\/j.cimid.2020.101574_bib0185","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance","volume":"100","author":"Rawat","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6387","key":"10.1016\/j.cimid.2020.101574_bib0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase\u2014peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0195","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.06460-11","article-title":"Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis","volume":"56","author":"Fenner","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"33","key":"10.1016\/j.cimid.2020.101574_bib0200","doi-asserted-by":"crossref","first-page":"27743","DOI":"10.1074\/jbc.M111.333385","article-title":"A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria","volume":"287","author":"Niki","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cimid.2020.101574_bib0205","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/jac\/dkt090","article-title":"High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations","volume":"68","author":"Machado","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0210","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/AAC.50.3.1075-1078.2006","article-title":"Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA","volume":"50","author":"Leung","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.cimid.2020.101574_bib0215","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1128\/AAC.33.9.1493","article-title":"Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis","volume":"33","author":"Takayama","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0597-567","article-title":"The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol","volume":"3","author":"Telenti","year":"1997","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","article-title":"Frequency of embB codon 306 mutations in ethambutol-susceptible and-resistant clinical Mycobacterium tuberculosis isolates in Kuwait","volume":"87","author":"Ahmad","year":"2007","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tube.2014.12.002","article-title":"ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis","volume":"95","author":"He","year":"2015","journal-title":"Tuberculosis"},{"issue":"RR-7","key":"10.1016\/j.cimid.2020.101574_bib0235","first-page":"1","article-title":"Prevention, Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"42","author":"Control","year":"1993","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0240","first-page":"461","article-title":"Pyrazinamide susceptibility and amidase activity of tubercle bacilli","volume":"95","author":"Konno","year":"1967","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0245","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.41.3.540","article-title":"Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis","volume":"41","author":"Scorpio","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0250","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0255","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","article-title":"Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot","volume":"9","author":"Finken","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cimid.2020.101574_bib0260","first-page":"354","article-title":"Multidrug-resistant tuberculosis","volume":"120","author":"Sharma","year":"2004","journal-title":"Indian J. Med. Res."},{"issue":"393","key":"10.1016\/j.cimid.2020.101574_bib0265","first-page":"75","article-title":"The assessment and treatment of drug-resistance problems in tuberculosis","volume":"63","author":"Crofton","year":"1970","journal-title":"J. Ir. Med. Assoc."},{"issue":"11","key":"10.1016\/j.cimid.2020.101574_bib0270","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1128\/AAC.40.11.2452","article-title":"Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis","volume":"40","author":"Meier","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-117-3-191","article-title":"Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers","volume":"117","author":"Pearson","year":"1992","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.cimid.2020.101574_bib0280","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/588292","article-title":"Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment","volume":"46","author":"Franke","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cimid.2020.101574_bib0285","series-title":"Resistance, Global Report on Surveillance","author":"Antimicrobial","year":"2014"},{"key":"10.1016\/j.cimid.2020.101574_bib0290","series-title":"Guidelines for the Programmatic Management of Drug-resistant Tuberculosis: Emergency Update 2008","author":"W.H. Organization","year":"2008"},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0295","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/jb.89.4.1068-1074.1965","article-title":"Mechanism of action of nalidixic acid on Escherichia coli II. Inhibition of deoxyribonucleic acid synthesis","volume":"89","author":"Goss","year":"1965","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0300","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.cimid.2020.101574_bib0305","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0310","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.48.2.596-601.2004","article-title":"Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates","volume":"48","author":"Cheng","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0315","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1574-6968.12401","article-title":"Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis","volume":"353","author":"Lu","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0325","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0330","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmyco.2015.09.001","article-title":"Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables","volume":"5","author":"Kambli","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7883\/yoken1952.16.31","article-title":"Studies on cross-resistance between capreomycin and certain other anti-mycobacterial agents","volume":"16","author":"Koseki","year":"1963","journal-title":"Jpn. J. Med. Sci. Biol."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2006.05.044","article-title":"Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2\u2032-O-methylations in 16S and 23S rRNAs","volume":"23","author":"Johansen","year":"2006","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0350","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","article-title":"Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis","volume":"49","author":"Maus","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.cimid.2020.101574_bib0355","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0360","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2958.2004.04120.x","article-title":"The folate pathway is a target for resistance to the drug para\u2010aminosalicylic acid (PAS) in mycobacteria","volume":"53","author":"Rengarajan","year":"2004","journal-title":"Mol. Microbiol."},{"issue":"32","key":"10.1016\/j.cimid.2020.101574_bib0365","doi-asserted-by":"crossref","first-page":"23447","DOI":"10.1074\/jbc.M113.475798","article-title":"Para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0370","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/AAC.01775-13","article-title":"Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis","volume":"58","author":"Zhao","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.cimid.2020.101574_bib0375","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/bi00860a038","article-title":"The biochemical mechanisms of resistance by streptococci to the antibiotics D-cycloserine and O-carbamyl-D-serine","volume":"6","author":"Reitz","year":"1967","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0380","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat. Genet."},{"issue":"16","key":"10.1016\/j.cimid.2020.101574_bib0385","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/jb.179.16.5046-5055.1997","article-title":"Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis","volume":"179","author":"Caceres","year":"1997","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.cimid.2020.101574_bib0390","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tim.2006.05.005","article-title":"Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm","volume":"14","author":"Nguyen","year":"2006","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jac\/46.3.391","article-title":"Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors","volume":"46","author":"Bosne-David","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.cimid.2020.101574_bib0400","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.00264-06","article-title":"Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible","volume":"50","author":"Andini","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cimid.2020.101574_bib0405","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.pharmtox.45.120403.100120","article-title":"The magic bullets and tuberculosis drug targets","volume":"45","author":"Zhang","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0410","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/AAC.01113-06","article-title":"First linezolid-resistant clinical isolates of Mycobacterium tuberculosis","volume":"51","author":"Richter","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0415","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.01189-07","article-title":"In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants","volume":"52","author":"Hillemann","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cimid.2020.101574_bib0420","article-title":"Clofazimine targets essential nucleoid associated protein, mycobacterial integration host factor (mIHF), in Mycobacterium tuberculosis","author":"Shi","year":"2017","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0425","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-resistant tuberculosis","volume":"9","author":"Jassal","year":"2009","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1183\/09031936.00136312","article-title":"Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis","volume":"42","author":"Migliori","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cimid.2020.101574_bib0440","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CLEP.S35839","article-title":"Extensively drug-resistant tuberculosis: epidemiology and management","volume":"6","author":"Matteelli","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0445","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12264","article-title":"Totally drug\u2010resistant tuberculosis and adjunct therapies","volume":"277","author":"Parida","year":"2015","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.cimid.2020.101574_bib0450","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3201\/eid1411.080729","article-title":"Multidrug-and extensively drug-resistant tuberculosis, Germany","volume":"14","author":"Eker","year":"2008","journal-title":"Emerging Infect. Dis."},{"issue":"9728","key":"10.1016\/j.cimid.2020.101574_bib0455","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cimid.2020.101574_bib0460","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm1102","article-title":"Modeling the emergence of the\u2019hot zones\u2019: tuberculosis and the amplification dynamics of drug resistance","volume":"10","author":"Blower","year":"2004","journal-title":"Nat. Med."},{"issue":"9547","key":"10.1016\/j.cimid.2020.101574_bib0465","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cimid.2020.101574_bib0470","series-title":"Multidrug and Extensively Drug-resistant TB (M","author":"W.H. Organization","year":"2010"},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0475","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MCP.0b013e3280f3c0b2","article-title":"The clinical management of drug-resistant tuberculosis","volume":"13","author":"Furin","year":"2007","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0480","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis","volume":"40","author":"Sotgiu","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0485","first-page":"118","article-title":"Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis","volume":"25","author":"Amaral","year":"2012","journal-title":"Acta Med. Port."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0490","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jac\/dks389","article-title":"Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"68","author":"Dey","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.cimid.2020.101574_bib0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1060028013504087","article-title":"Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis","volume":"48","author":"Chahine","year":"2014","journal-title":"Ann. Pharmacother."},{"issue":"37","key":"10.1016\/j.cimid.2020.101574_bib0500","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M803899200","article-title":"Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis","volume":"283","author":"Koul","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5707","key":"10.1016\/j.cimid.2020.101574_bib0505","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0510","doi-asserted-by":"crossref","first-page":"e00239","DOI":"10.1128\/AAC.00239-17","article-title":"Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis","volume":"61","author":"Xu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0515","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jac\/dkm291","article-title":"Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis","volume":"60","author":"Saliu","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"20","key":"10.1016\/j.cimid.2020.101574_bib0520","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis","volume":"373","author":"Bloemberg","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0525","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jac\/dkw044","article-title":"Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECTM MGITTM 960 system","volume":"71","author":"Schena","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"6789","key":"10.1016\/j.cimid.2020.101574_bib0530","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0535","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.05708-11","article-title":"SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis","volume":"56","author":"Tahlan","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.cimid.2020.101574_bib0540","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0545","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1183\/09031936.00064510","article-title":"New insight into extremely drug-resistant tuberculosis: using atomic force microscopy","volume":"36","author":"Velayati","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0550","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/\/EID1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerging Infect. Dis."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0555","first-page":"307","article-title":"The totally drug resistant tuberculosis (TDR-TB)","volume":"6","author":"Velayati","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0560","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh","year":"2020","journal-title":"J. Appl. Microbiol."},{"issue":"7551","key":"10.1016\/j.cimid.2020.101574_bib0565","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.332.7551.1194","article-title":"Pulmonary tuberculosis: diagnosis and treatment","volume":"332","author":"Campbell","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cimid.2020.101574_bib0570","series-title":"Global Tuberculosis Report 2017","author":"W.H. Organisation","year":"2017"},{"issue":"6","key":"10.1016\/j.cimid.2020.101574_bib0575","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cmi.2017.10.030","article-title":"Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential?","volume":"24","author":"Satta","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"issue":"15","key":"10.1016\/j.cimid.2020.101574_bib0580","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"Consortium, G.P. The 100","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cimid.2020.101574_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.04.039","article-title":"Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.cimid.2020.101574_bib0590","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.5588\/ijtld.15.0926","article-title":"Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review","volume":"20","author":"Pande","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"7","key":"10.1016\/j.cimid.2020.101574_bib0595","article-title":"Tuberculosis\u2014an overview","volume":"1","author":"Agyeman","year":"2017","journal-title":"J. Public Health Emerg."},{"issue":"10144","key":"10.1016\/j.cimid.2020.101574_bib0600","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cimid.2020.101574_bib0605","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10096-018-3258-y","article-title":"Recent advances in tuberculosis diagnostics in resource-limited settings","volume":"37","author":"Seki","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.cimid.2020.101574_bib0610","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cmi.2015.08.024","article-title":"Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay","volume":"21","author":"Nguyen","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cimid.2020.101574_bib0615","series-title":"Treatment of Tuberculosis: Guidelines","author":"W.H. Organization","year":"2010"},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0620","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jamainternmed.2018.0141","article-title":"Daily vs intermittent antituberculosis therapy for pulmonary tuberculosis in patients with HIV: a randomized clinical trial","volume":"178","author":"Gopalan","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cimid.2020.101574_bib0625","article-title":"Review of available evidence on the use of bedaquiline for the treatment of multidrug-resistant tuberculosis: Data analysis report","author":"Mbuagbaw","year":"2017","journal-title":"Version"},{"issue":"9","key":"10.1016\/j.cimid.2020.101574_bib0630","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.cimid.2020.101574_bib0635","first-page":"839","article-title":"Inhibition by streptomycin of tubercle bacilli within cultured human macrophages","volume":"130","author":"Crowle","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cimid.2020.101574_bib0640","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","author":"Falzon","year":"2011","journal-title":"Eur Respiratory Soc"},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0645","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0650","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cimid.2020.101574_bib0655","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.297.4.380","article-title":"Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial","volume":"297","author":"Thiam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cimid.2020.101574_bib0660","series-title":"WHO Policy on TB Infection Control in Health-care Facilities, Congregate Settings and Households","author":"W.H. Organization","year":"2009"},{"issue":"17","key":"10.1016\/j.cimid.2020.101574_bib0665","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cimid.2020.101574_bib0670","series-title":"Guidance Paper: WHO Support to Countries in Accessing and Utilizing Resources From the Global Fund to Fight AIDS, TB and Malaria: Geneva, November 2009","author":"W.H. Organization","year":"2010"},{"issue":"12","key":"10.1016\/j.cimid.2020.101574_bib0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030494","article-title":"Tuberculosis among health-care workers in low-and middle-income countries: a systematic review","volume":"3","author":"Joshi","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.cimid.2020.101574_bib0680","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.11.0605","article-title":"Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area","volume":"16","author":"van der Werf","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957120301636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957120301636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:45:27Z","timestamp":1758955527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957120301636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":136,"alternative-id":["S0147957120301636"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2020.101574","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistant Tuberculosis: A review","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2020.101574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101574"}}